BEGIN:VCALENDAR
VERSION:2.0
METHOD:PUBLISH
CALSCALE:GREGORIAN
PRODID:-//WordPress - MECv6.1.6//EN
X-ORIGINAL-URL:https://swecham.ch/
X-WR-CALNAME:Swedish Swiss Chamber of Commerce
X-WR-CALDESC:Networking organisation for companies and individuals
REFRESH-INTERVAL;VALUE=DURATION:PT1H
X-PUBLISHED-TTL:PT1H
X-MS-OLK-FORCEINSPECTOROPEN:TRUE
BEGIN:VEVENT
CLASS:PUBLIC
UID:MEC-db346ccb62d491029b590bbbf0f5c412@swecham.ch
DTSTART:20211117T170000Z
DTEND:20211117T183000Z
DTSTAMP:20221026T082800Z
CREATED:20221026
LAST-MODIFIED:20221026
PRIORITY:5
TRANSP:OPAQUE
SUMMARY:AICC EVENT: Meet Per Falk, President of Ferring Pharmaceuticals – Geneva
DESCRIPTION:THE IMPORTANCE OF COLLABORATION IN THE PHARMACEUTICAL INDUSTRY\nThe Swedish Swiss Chamber of Commerce in collaboration with AICC have the pleasure of inviting you to a networking event taking place on Wednesday 17 November in Geneva.\nFerring is a research-driven, specialty biopharmaceutical group committed to helping people build healthy families and live better lives. Ferring is a leader in reproductive medicine and maternal health, and in specialty areas within gastroenterology and urology.\nSPEAKER\nPer Falk, President of Ferring Pharmaceuticals\nPer joined Ferring Pharmaceuticals in 2015 and was appointed President on January 1st, 2019. Privately-owned, Ferring is a research-driven, speciality biopharmaceutical group committed to helping people around the world build families and live better lives. The company is a leader in reproductive medicine and maternal health, and in speciality areas within gastroenterology and urology. Ferring has been developing treatments for mothers and babies for over 50 years and has a portfolio covering treatments from conception to birth.\nPer previously held executive and senior leadership positions in research, medical and clinical development at Novo Nordisk and AstraZeneca. Before joining the pharmaceutical industry, he held the position of Associate Professor at the Karolinska Institute, Sweden, and Washington University School of Medicine, USA. Per has an M.D. degree and a Ph.D. in Biochemistry and Clinical Chemistry from Gothenburg University, Sweden.\nPer will talk about Ferring and their commitment in reproductive medicine and maternal health and how they address inequalities, as well as how the pandemic has impacted this area. He will also discuss how the pharma / life science industry can work better with regulators, politicians and the media in developing public health policies.\nPROGRAMME\n18:00   Welcome and Registration\n18:45   Presentation followed by Q&A\n19:30   Apéro and Networking\nDon’t miss this excellent opportunity to network with members from 15 bilateral chambers of commerce in Switzerland.\nFEES\nCHF 40 for SSCC Members\nCHF 60 for non-SSCC Members\nWelcome!\nKINDLY SPONSORED BY\nIN COLLABORATION WITH\nCOVID-19\nThe Swedish Swiss Chamber of Commerce is continually monitoring government and health guidelines to protect our team and our guests. Along with the venue provider, we want to provide a safe environment. All guests must comply with government recommendations with regards to self-isolation and if you are feeling unwell or showing any symptoms, we kindly ask you to stay at home.\nWe follow the official rules (GGG – geimpft, genesen, getestet). To gain access to the event, please be ready to present one of the required Covid certificates.\nIf you have any questions or concerns, please get in touch with the SSCC.\n\n
URL:https://swecham.ch/events/aicc-event-meet-per-falk-president-of-ferring-pharmaceuticals-geneva/
CATEGORIES:Events
LOCATION:Route François-Peyrot 34, 1218 Le Grand-Saconnex
ATTACH;FMTTYPE=image/png:https://swecham.ch/wp-content/uploads/2022/10/Event-pic-1.png
END:VEVENT
END:VCALENDAR